We’re looking for individuals diagnosed with ulcerative colitis who may still be experiencing symptoms despite current treatment.
TELL ME MORE



Ulcerative colitis (UC) affects hundreds of thousands of people in the U.S., and in communities of color, it can be more severe and harder to manage. UC is a chronic inflammatory bowel disease that causes inflammation and ulcers in the digestive tract, leading to flare-ups that impact daily life.
By taking part in this research, you can help improve care for people living with UC today and for the generations that come after you.

Have been diagnosed with ulcerative colitis (UC)
Continue to experience symptoms despite treatment
Are an adult aged 18–80
Meet other health and eligibility requirements
Potentially access a study treatment before it’s widely available
Benefit from study-related health assessments during your participation
Contribute to research that can improve care for future generations
A member of our team will review the study criteria with you to see if you’re eligible
Your voice matters.
Your participation matters.
See if you qualify today — it only takes a few minutes.
Research often misses the voices of people in communities of color. Without that representation, treatments may not work as well for everyone. By participating, you help ensure future care is designed with your community in mind.
When we are included in clinical research for ulcerative colitis or any other condition, we can understand how safe and effective new treatments can be for us.
By participating in clinical research, we have the opportunity to build a healthier community.
If you still have questions, you are not alone.
NOWINCLUDED, created by Acclinate, is a community created for us to:
Get the resources we need to improve our health
Feel seen and heard in healthcare decisions
Be empowered to make our own decisions for our health, like clinical research participation
© Acclinate, Inc. 2025 This website is published by Acclinate, Inc which is solely responsible for its content. This site is intended for U.S. residents.
Privacy Policy